Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Non-Current Debt (2016 - 2025)

Historic Non-Current Debt for Phibro Animal Health (PAHC) over the last 13 years, with Q4 2025 value amounting to $603.6 million.

  • Phibro Animal Health's Non-Current Debt fell 309.5% to $603.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $603.6 million, marking a year-over-year decrease of 309.5%. This contributed to the annual value of $615.4 million for FY2025, which is 11801.59% up from last year.
  • Latest data reveals that Phibro Animal Health reported Non-Current Debt of $603.6 million as of Q4 2025, which was down 309.5% from $609.5 million recorded in Q3 2025.
  • In the past 5 years, Phibro Animal Health's Non-Current Debt ranged from a high of $622.9 million in Q4 2024 and a low of $180.8 million during Q1 2021
  • Its 5-year average for Non-Current Debt is $362.9 million, with a median of $287.7 million in 2021.
  • As far as peak fluctuations go, Phibro Animal Health's Non-Current Debt crashed by 1131.46% in 2021, and later surged by 11801.59% in 2025.
  • Quarter analysis of 5 years shows Phibro Animal Health's Non-Current Debt stood at $280.3 million in 2021, then fell by 1.25% to $276.8 million in 2022, then grew by 7.6% to $297.9 million in 2023, then soared by 109.12% to $622.9 million in 2024, then fell by 3.09% to $603.6 million in 2025.
  • Its last three reported values are $603.6 million in Q4 2025, $609.5 million for Q3 2025, and $615.4 million during Q2 2025.